A nurse provided education to a client with a new prescription for methimazole. Which client statement indicates an understanding of the education?

1. A. The time period that a drug elicits a therapeutic response: Duration of action refers to the length of time a drug maintains its therapeutic effect at a level sufficient to produce the desired clinical outcome. It is influenced by the drug’s half-life, metabolism, and elimination, and helps guide appropriate dosing intervals to maintain efficacy.

   B. The maximum therapeutic effect of a drug: This describes the drug’s peak effect or maximum efficacy, not the duration of action. Peak effect reflects the highest intensity of response rather than the total time the drug remains effective.

   C. The moment when the drug stops producing an effect: While the drug ceasing to produce an effect marks the end of its duration, duration of action is defined by the entire time period of therapeutic effect, not a single endpoint.

   D. The point at which a drug is excreted from the body: Excretion refers to the elimination of the drug from the body via renal, hepatic, or other pathways. Drug elimination does not necessarily correlate with duration of action, as some drugs can continue to have effects after plasma levels decline.

A. Thromboembolism: Estradiol, as an estrogen therapy, increases the risk of thromboembolic events by promoting hepatic synthesis of clotting factors and altering the balance of procoagulant and anticoagulant proteins. This can lead to deep vein thrombosis, pulmonary embolism, or stroke, particularly in clients with additional risk factors.

B. Hyperglycemia: Estradiol does not typically cause elevated blood glucose. Its primary metabolic effects involve reproductive and cardiovascular systems, not glucose regulation, so hyperglycemia is not a common adverse effect.

C. Blurry vision: While ocular changes may occur with hormonal fluctuations, blurry vision is not a common or significant adverse effect of estradiol therapy. Severe visual changes would warrant evaluation for other causes.

D. Increased urination: Estradiol does not usually affect urine output. Increased urination is not pharmacologically linked to estrogen therapy and would require assessment for alternative etiologies such as diabetes or diuretic use.